Warfarin is a natural product and given as racemic mixture of the R and S stereoisomers of the drug. S-warfarin is 3-5 times more potent an inhibitor of the vitamin K epoxide reductase complex, the target of action, than R-warfarin [Article:3567019]. The stereoisomers are metabolized by different phase 1 enzymes; the predominant metabolism of the S isomer is via CYP2C9 whereas metabolism of R-warfarin is mainly via CYP3A4 with involvement of CYP1A1, CYP1A2, CYP2C8, CYP2C9, CYP2C18 and CYP2C19 [Articles:1581537, 11353757, 8689941, 8723744] as depicted in the Warfarin Pharmacokinetics Pathway. Phase 2 metabolism of warfarin has not been well studied and is not depicted in this pathway representation, although it is known that sulfated and glucuronyl conjugates can be formed [Article:1732719]. Elimination is predominantly renal however warfarin has been shown to interact with the ABCB1 transporter in liver [Article:14676821].
until we switched to brand name Coumadin..
This is the first time I've heard of Marevan.
...
My experience with the generic was so worrisome I'm not about to go back to generic.
Enter your email address to join: